InvestorsHub Logo
Post# of 232
Followers 18
Posts 1387
Boards Moderated 0
Alias Born 10/21/2015

Re: None

Monday, 01/30/2017 11:45:32 AM

Monday, January 30, 2017 11:45:32 AM

Post# of 232
This stock is way undervalued, especially compared to Cannabix. Cannabix is infinitely less likely to become successful with faims and breathtec not only is using faims to identify abundant compounds that are much easier to detect, but breathtec also has Na-nose which is government tested and is in clinical trials (approved).

Yet it trades for a quarter of Cannabix. People overlook scientific fact and data and invest on the theory of a device. It's silly.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.